Commencement of Atorvastatin and Ezetimibe immediately in patients presenting with acute coronary syndrome
Sallam, Mohammed
Sallam, Mohammed
Abstract
Lipids are implicated in the development of coronary atherosclerosis. Achieving a significant reduction in lipid levels remains a crucial aspect of secondary prevention following an acute coronary syndrome event. Novel lipid-lowering therapies now provide clinicians with a variety of therapeutic strategies to choose from and tailor to individual patient needs. This review focuses on evidence supporting the importance of early and intensive lipid-lowering therapy use in patients presenting with acute coronary syndrome, specifically addressing data relating to atorvastatin and ezetimibe use in this high-risk cohort of patients.
Affiliations
Sandwell and West Birmingham NHS Trust
Citations
Altmetric:
Date
2024-11-12
Type
Article
Subject
Citation
allam M, Hassan H, Connolly D, Rahman MS. Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome. Eur Cardiol. 2024 Nov 12;19:e22. doi: 10.15420/ecr.2024.06